The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis

Journal of Gastroenterology

Volumn 42, Issue 6, 2007, Pages 475-484

  Jin, Haiyan ^a,b   Terai, Shuji ^a   Sakaida, Isao ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YANBIAN UNIVERSITY   (China)

Author keywords

Apoptosis; Deferoxamine; Fibrosis; Hepatic stellate cell(s); Peroxisome proliferator activated receptor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOCHROME C; DEFEROXAMINE; FERRIC CHLORIDE; GELATINASE A; GELATINASE B; IRON CHELATING AGENT; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROCOLLAGEN; PROTEIN BCL 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOSOL; DATA ANALYSIS; ENZYME ACTIVITY; IRON CHELATION; LIVER CELL; LIVER FIBROSIS; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL;

ANIMALS; APOPTOSIS; CHELATING AGENTS; DEFEROXAMINE; HEPATOCYTES; IRON; MALE; RATS; RATS, WISTAR;

EID: 34447340635     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2020-5     Document Type: Article

References (34)

1. SL Friedman 1993 The cellular basis of hepatic fibrosis - mechanisms and treatment strategies N Engl J Med 328 1828-35 8502273 10.1056/ NEJM199306243282508
2. ML Hautekeete A Geerts 1997 The hepatic stellate (Ito) cell: Its role in human liver disease Virchows Arch 430 195-207 9099976 10.1007/BF01324802
3. SL Friedman JJ Maher DM Bissell 2000 Mechanisms and therapy of hepatic fibrosis: Report of the AASLD Single Topic Basic Research Conference Hepatology 32 1403-8 11093750 10.1053/jhep.2000.20243
4. T Knittel M Mehde A Grundmann B Saile JG Scharf G Ramadori 2000 Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat Histochem Cell Biol 113 443-53 10933221
5. JP Iredale 2001 Hepatic stellate cell behavior during resolution of liver injury Semin Liver Dis 21 427-36 11586470 10.1055/s-2001-17557
6. N Rakba P Loyer D Gilot JG Delcros D Glaise P Baret 2000 Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines Carcinogenesis 21 943-51 10783316 10.1093/carcin/21.5.943
7. A Kicic AC Chua E Baker 2001 Effect of iron chelators on proliferation and iron uptake in hepatoma cells Cancer 92 3093-110 11753989 10.1002/ 1097-0142(20011215)92:12<3093::AID-CNCR10107>3.0.CO;2-B
8. E Porreca S Ucchino C Di Febbo N Di Bartolomeo D Angelucci AM Napolitano 1994 Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo Arterioscler Thromb 14 299-304 8305423
9. K Fukuchi S Tomoyasu N Tsuruoka K Gomi 1994 Iron deprivation-induced apoptosis in HL-60 cells FEBS Lett 350 139-42 8062913 10.1016/ 0014-5793(94)00755-1
10. I Sakaida ME Kyle JL Farber 1990 Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress Mol Pharmacol 37 435-42 2314391
11. I Sakaida AP Thomas JL Farber 1991 Increases in cytosolic calcium ion concentration can be dissociated from the killing of cultured hepatocytes by tert-butyl hydroperoxide J Biol Chem 266 717-22 1985959
12. I Sakaida K Kayano S Wasaki A Nagatomi Y Matsumura K Okita 1995 Protection against acetaminophen-induced liver injury in vivo by an iron chelator, deferoxamine Scand J Gastroenterol 30 61-7 7701253
13. I Sakaida K Hironaka K Uchida K Okita 1999 Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats Dig Dis Sci 44 560-9 10080151 10.1023/ A:1026661508553
14. I Sakaida K Okita 2005 The role of oxidative stress in NASH and fatty liver model Hepatol Res 33 128-31 16214393 10.1016/j.hepres.2005.09.019
15. J Blatt S Stitely 1987 Antineuroblastoma activity of desferoxamine in human cell lines Cancer Res 47 1749-50 3815370
16. D Richardson P Ponka E Baker 1994 The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell Cancer Res 54 685-9 8306330 D Richardson P Ponka E Baker
17. H Jin I Sakaida M Tsuchiya K Okita 2005 Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet Life Sci 76 2805-16 15808881 10.1016/j.lfs.2004.09.041
18. K Kawaguchi I Sakaida M Tsuchiya K Omori T Takami K Okita 2004 Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet Biochem Biophys Res Commun 315 187-95 15013444 10.1016/ j.bbrc.2004.01.038
19. I Sakaida K Hironaka K Uchida C Suzuki K Kayano K Okita 1998 Fibrosis accelerates the development of enzyme-altered lesions in the rat liver Hepatology 28 1247-52 9794908 10.1002/hep.510280512
20. NK Saxena K Ikeda DC Rockey SL Friedman FA Anania 2002 Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice Hepatology 35 762-71 11915021 10.1053/ jhep.2002.32029
21. MJ Arthur II Fibrogenesis 2000 Metalloproteinases and their inhibitors in liver fibrosis Am J Physiol Gastrointest Liver Physiol 279 G245-9 10915630
22. RC Benyon CJ Hovell M Da Gaca EH Jones JP Iredale MJ Arthur 1999 Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation Hepatology 30 977-86 10498650 10.1002/ hep.510300431
23. N Theret K Lehti O Musso B Clement 1999 MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells Hepatology 30 462-8 10421655 10.1002/hep.510300236
24. AE Kossakowska DR Edwards SS Lee LS Urbanski AL Stabbler CL Zhang 1998 Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis Am J Pathol 153 1895-902 9846979
25. RC Benyon JP Iredale S Goddard PJ Winwood MJ Arthur 1996 Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver Gastroenterology 110 821-31 8608892 10.1053/ gast.1996.v110.pm8608892
26. RA Weinberg 1995 The retinoblastoma protein and cell cycle control Cell 81 323-30 7736585 10.1016/0092-8674(95)90385-2
27. M Yamada WS Blaner DR Soprano JL Dixon HM Kjeldbye DS Goodman 1987 Biochemical characteristics of isolated rat liver stellate cells Hepatology 7 1224-9 2824313 10.1002/hep.1840070609
28. S Hazra S Xiong J Wang RA Rippe V Krishna K Chatterjee 2004 Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells J Biol Chem 279 11392-401 14702344 10.1074/jbc.M310284200
29. H She S Xiong S Hazra H Tsukamoto 2005 Adipogenic transcriptional regulation of hepatic stellate cells J Biol Chem 280 4959-67 15537655 10.1074/jbc.M410078200
30. JJ Repa G Liang J Ou Y Bashmakov JM Lobaccaro I Shimomura 2000 Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta Genes Dev 14 2819-30 11090130 10.1101/gad.844900
31. KR Bridle DH Crawford GA Ramm 2003 Identification and characterization of the hepatic stellate cell transferrin receptor Am J Pathol 162 1661-7 12707050
32. FJ Alcain H Low FL Crane 1994 Iron at the cell surface controls DNA synthesis in CCl 39 cells Biochem Biophys Res Commun 203 16-21 8074650 10.1006/bbrc.1994.2142
33. JG Sibille M Ciriolo H Kondo RR Crichton P Aisen 1989 Subcellular localization of ferritin and iron taken up by rat hepatocytes Biochem J 262 685-8 2803277
34. H Cable JB Lloyd 1999 Cellular uptake and release of two contrasting iron chelators J Pharm Pharmacol 51 131-4 10217310 10.1211/ 0022357991772231